Miscibility of semisynthetic human ultralente insulin with short-acting insulin in insulin-dependent diabetic patients

1988 ◽  
Vol 25 (3) ◽  
pp. 263-269
Author(s):  
Michele Lunetta ◽  
Maurizio di Mauro ◽  
Salvatore Crimi ◽  
Luciana Sudano ◽  
Lanfranco Mughini
Keyword(s):  
Diabetic Patients ◽  
Short Acting ◽  
Acting Insulin ◽  
Short Acting Insulin ◽  
Insulin Dependent ◽  
Insulin Dependent Diabetic

Early and late onset side effects of short-acting insulin analogue in seven Japanese diabetic patients

2007 ◽  
Vol 77 (3) ◽  
pp. 412-413 ◽  
Author(s):  
Akira Kuroe ◽  
Ataru Taniuguchi ◽  
Mitsuo Fukushima ◽  
Yoshikatsu Nakai ◽  
Minako Ohgushi ◽  
...  
Keyword(s):  
Side Effects ◽  
Insulin Analogue ◽  
Late Onset ◽  
Diabetic Patients ◽  
Short Acting ◽  
Acting Insulin ◽  
Short Acting Insulin

When to consider continuous subcutaneous insulin infusion (CSII)

1987 ◽  
Vol 25 (7) ◽  
pp. 25-28
Keyword(s):  
Blood Glucose ◽  
Glucose Control ◽  
Blood Glucose Control ◽  
Diabetic Patients ◽  
Short Acting ◽  
Glucose Levels ◽  
Acting Insulin ◽  
Short Acting Insulin ◽  
Portable Pump ◽  
Long Acting

Most physicians agree that the aim of diabetic management is to achieve the best possible blood glucose control without troublesome hypoglycaemia. Continuous subcutaneous infusion of insulin (CSII) via a battery-operated portable pump was introduced in 1977 with this aim, originally as a research technique to study the effects of prolonged near-physiological blood glucose levels in diabetic patients.1 It provides a continuous basal supply of unmodified, short-acting insulin throughout 24 hours with supplementary boluses before main meals, activated by the user from the same pump. Its introduction coincided with the move towards intensified conventional therapy (ICT) together with better education: improved blood-sugar control with self-monitoring of capillary blood glucose, more frequent insulin injections when necessary, and measurement of glycosylated haemoglobin (an index of average blood glucose control over the preceding month). The aim of ICT is to maintain a continuous basal supply of insulin using a long-acting insulin with bolus injections of short-acting insulin to cover meals.

Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients

Diabetes ◽  
1985 ◽  
Vol 34 (11) ◽  
pp. 1127-1133 ◽  
Author(s):  
R. K. Mayfield ◽  
P. V. Halushka ◽  
H. J. Wohltmann ◽  
M. Lopes-Virella ◽  
J. K. Chambers ◽  
...  
Keyword(s):  
Platelet Function ◽  
Insulin Infusion ◽  
Diabetic Patients ◽  
Insulin Dependent ◽  
Insulin Dependent Diabetic ◽  
Continuous Insulin Infusion
Sign in / Sign up

Export Citation Format

Share Document